Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...
Scientists from the University of Pennsylvania have identified an immune-system protein that facilitates the spread of ...
Northwestern Medicine scientists have discovered that suppressing excitatory synaptic transmission in a small group of ...
Symptoms of Parkinson’s disease can affect your daily life and well-being. Nourianz (istradefylline) is a medicine used to reduce “off” time in people with Parkinson’s disease who are taking daily ...
New research identifies two main Parkinson's disease subtypes and five subgroups, explaining why single treatments often fail ...
Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...
Despite their differences, Alzheimer’s disease and Parkinson’s disease share several risk factors and mechanisms of neuronal damage. Both also feature a phase that precedes the appearance of symptoms ...
BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that the last ...